Evogene Ltd Ord (EVGN) Stock Price, Quote & News

Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segmen...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 8 931 1900

Fax: 972 8 946 6724

Website: www.evogene.com

Address:

13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel

MochiMeerkat Feb. 23 at 5:39 PM

.@SqueezeSharkie moving different. .Ice-cold vision, pure substance. Costs you nothing but a tap, follow him now!! $TOVX $SPRB $IPHA $EVGN *^

0 · Reply

OfficialStocktwitsUser Feb. 21 at 10:11 AM

$EVGN RSI: 30.61, MACD: -0.0435 Vol: 0.07, MA20: 1.01, MA50: 1.04 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

GPDL Feb. 21 at 5:17 AM

$EVGN Market cap is messed up for the company value on a sale, all is worth about 30-40 million, bad management, huge upside one day

0 · Reply

cowboygold Feb. 20 at 6:25 PM

$EVGN what a joke. Unreal. Total waste of time and money. We should hire a lawyer and fuck these greedy bums

0 · Reply

Bettt Feb. 20 at 6:18 PM

$EVGN

0 · Reply

FactorMomentum Feb. 20 at 1:57 PM

$EVGN Evogene develops computational biology platforms. Revenue depends on partnerships. Commercial adoption remains early.

0 · Reply

BillionerOfKing Feb. 17 at 4:25 PM

$EVGN Current Stock Price: $0.96

0 · Reply

Stock_Catcher Feb. 17 at 1:02 PM

$EVGN EVGN Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

0 · Reply

Stock_Catcher Feb. 11 at 1:01 PM

$EVGN EVGN Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

0 · Reply

mikesterz7 Feb. 10 at 9:30 PM

$EVGN Evogene on Tuesday announced that it had entered into a warrant inducement agreement for about $3.4 million with an existing institutional investor.

0 · Reply

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

2026-02-17T13:33:51.000Z - 6 days ago

Evogene (EVGN) Partners with QUT to Combat Lung Cancer Drug Resistance

Tue, 17 Feb 2026 08:00:00 -0500 - 7 days ago

Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

Wed, 11 Feb 2026 08:00:00 -0500 - 13 days ago

Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

Tue, 10 Feb 2026 13:20:00 -0500 - 13 days ago

Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds

2026-02-10T13:29:55.000Z - 14 days ago

Evogene (EVGN) Expands Collaboration with Google Cloud to Boost AI Capabilities

Tue, 10 Feb 2026 08:00:00 -0500 - 14 days ago

Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™

Mon, 09 Feb 2026 08:00:00 -0500 - 15 days ago

Evogene Appoints Prof. John Irwin and Prof.

2026-02-05T11:26:12.000Z - 19 days ago

Evogene (EVGN) Subsidiary Biomica Secures Licensing Deal for Innovative Cancer Therapy

Wed, 04 Feb 2026 22:00:00 -0500 - 19 days ago

Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer

2026-02-04T13:41:08.000Z - 19 days ago

Evogene (EVGN) Signs Licensing Agreement for Promising Cancer Therapy

2026-01-07T12:30:48.000Z - 6 weeks ago

Evogene (EVGN) and Unravel Biosciences Partner to Tackle Neurological Diseases

Wed, 07 Jan 2026 07:00:00 -0500 - 6 weeks ago

Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

Tue, 30 Dec 2025 07:00:00 -0500 - 2 months ago

Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development

Thu, 11 Dec 2025 18:22:48 -0500 - 2 months ago

EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Fri, 21 Nov 2025 12:13:24 -0500 - 3 months ago

EverGen Infrastructure Corp. (EVGN:CA) Q3 2025 Earnings Call Transcript

2025-11-20T17:13:26.000Z - 3 months ago

Evogene Ltd. (EVGN) Q3 2025 Earnings Call Transcript

2025-11-20T12:11:17.000Z - 3 months ago

Evogene GAAP EPS of -$0.31 beats by $0.10, revenue of $0.31M misses by $0.34M

Thu, 20 Nov 2025 07:00:00 -0500 - 3 months ago

Evogene Reports Third Quarter 2025 Financial Results

2025-11-19T16:19:03.000Z - 3 months ago

Evogene Q3 2025 Earnings Preview

2025-11-19T16:03:33.000Z - 3 months ago

What's Next: Evogene's Earnings Preview

Tue, 11 Nov 2025 07:00:00 -0500 - 3 months ago

Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

Thu, 06 Nov 2025 09:00:00 -0500 - 3 months ago

Evogene Schedules Third Quarter 2025 Financial Results Release

Thu, 28 Aug 2025 07:00:00 -0400 - 6 months ago

Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

2025-08-19T17:31:58.000Z - 6 months ago

Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript

2025-08-19T11:03:58.000Z - 6 months ago

Evogene GAAP EPS of -$0.85 misses by $0.22, revenue of $0.88M misses by $0.05M

Tue, 19 Aug 2025 07:00:00 -0400 - 6 months ago

Evogene Reports Second Quarter 2025 Financial Results

2025-08-18T16:39:37.000Z - 6 months ago

Evogene Q2 2025 Earnings Preview

2025-08-18T15:02:56.000Z - 6 months ago

Preview: Evogene's Earnings

Tue, 12 Aug 2025 07:00:00 -0400 - 7 months ago

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

Tue, 29 Jul 2025 07:00:00 -0400 - 7 months ago

Evogene Schedules Second Quarter 2025 Financial Results Release

Tue, 08 Jul 2025 07:00:00 -0400 - 8 months ago

Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL

Tue, 10 Jun 2025 07:00:00 -0400 - 9 months ago

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

2025-05-21T18:08:24.000Z - 9 months ago

Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript

2025-05-21T11:03:44.000Z - 9 months ago

Evogene GAAP EPS of -$0.38, revenue of $2.44M

Wed, 21 May 2025 07:00:00 -0400 - 9 months ago

Evogene Reports First Quarter 2025 Financial Results

2025-05-20T18:47:04.000Z - 9 months ago

Evogene Q1 2025 Earnings Preview

2025-05-20T15:02:35.000Z - 9 months ago

Insights into Evogene's Upcoming Earnings

Thu, 08 May 2025 07:00:00 -0400 - 10 months ago

Evogene Schedules First Quarter 2025 Financial Results Release

Mon, 21 Apr 2025 07:00:00 -0400 - 11 months ago

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

2025-03-06T17:48:23.000Z - 1 year ago

Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript

2025-03-06T12:19:39.000Z - 1 year ago

Evogene GAAP EPS of -$0.06 beats by $0.66, revenue of $1.61M misses by $2.02M

2025-03-06T12:18:32.000Z - 1 year ago

Evogene appoints Nir Nimrodi as new chair

Thu, 06 Mar 2025 07:15:00 -0500 - 1 year ago

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Thu, 06 Mar 2025 07:00:00 -0500 - 1 year ago

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

2025-03-06T08:32:20.000Z - 1 year ago

Earnings Scheduled For March 6, 2025

2025-03-05T17:47:04.000Z - 1 year ago

Evogene Q4 2024 Earnings Preview

Thu, 20 Feb 2025 07:00:00 -0500 - 1 year ago

Evogene Schedules Fourth Quarter 2024 Financial Results Release

Thu, 13 Feb 2025 08:00:00 -0500 - 1 year ago

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

2024-11-22T07:04:36.000Z - 1 year ago

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

Nov 21, 2024, 1:46 PM EST - 1 year ago

Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript

Nov 21, 2024, 7:30 AM EST - 1 year ago

Evogene Reports Third Quarter 2024 Financial Results

Nov 19, 2024, 7:00 AM EST - 1 year ago

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Nov 12, 2024, 7:00 AM EST - 1 year ago

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Nov 7, 2024, 7:00 AM EST - 1 year ago

Evogene Schedules Third Quarter 2024 Financial Results Release

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Oct 8, 2024, 7:00 AM EDT - 1 year ago

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Sep 30, 2024, 7:00 AM EDT - 1 year ago

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Aug 23, 2024, 8:55 AM EDT - 1 year ago

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

Aug 22, 2024, 5:42 PM EDT - 1 year ago

Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 7:00 AM EDT - 1 year ago

Evogene Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 7:11 AM EDT - 1 year ago

Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Evogene Schedules Second Quarter 2024 Financial Results Release

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil

Jul 23, 2024, 8:48 AM EDT - 1 year ago

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

Jul 17, 2024, 8:00 AM EDT - 1 year ago

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

ICL

Jul 2, 2024, 7:00 AM EDT - 1 year ago

Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Jun 25, 2024, 7:00 AM EDT - 1 year ago

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

MochiMeerkat Feb. 23 at 5:39 PM

.@SqueezeSharkie moving different. .Ice-cold vision, pure substance. Costs you nothing but a tap, follow him now!! $TOVX $SPRB $IPHA $EVGN *^

0 · Reply

OfficialStocktwitsUser Feb. 21 at 10:11 AM

0 · Reply

GPDL Feb. 21 at 5:17 AM

$EVGN Market cap is messed up for the company value on a sale, all is worth about 30-40 million, bad management, huge upside one day

0 · Reply

cowboygold Feb. 20 at 6:25 PM

$EVGN what a joke. Unreal. Total waste of time and money. We should hire a lawyer and fuck these greedy bums

0 · Reply

Bettt Feb. 20 at 6:18 PM

$EVGN

0 · Reply

FactorMomentum Feb. 20 at 1:57 PM

$EVGN Evogene develops computational biology platforms. Revenue depends on partnerships. Commercial adoption remains early.

0 · Reply

BillionerOfKing Feb. 17 at 4:25 PM

$EVGN Current Stock Price: $0.96

0 · Reply

Stock_Catcher Feb. 17 at 1:02 PM

$EVGN EVGN Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

0 · Reply

Stock_Catcher Feb. 11 at 1:01 PM

$EVGN EVGN Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

0 · Reply

mikesterz7 Feb. 10 at 9:30 PM

$EVGN Evogene on Tuesday announced that it had entered into a warrant inducement agreement for about $3.4 million with an existing institutional investor.

0 · Reply

_2025 Feb. 10 at 8:56 PM

$EVGN The warrant inducement at $1.00 is a steal. This institution will likely offload their position at a significant premium once the registration is effective. Strong buy opportunity here

0 · Reply

Trader1141 Feb. 10 at 8:35 PM

$EVGN they havent dismantled the lies abiuy $GOOGL Collab? 🤣🤣🤣

0 · Reply

StocktwitsNews Feb. 10 at 8:10 PM

Why Did EVGN Shares Drop More Than 14% Today? $EVGN https://stocktwits.com/news/equity/markets/why-did-evgn-shares-drop-today/cZbU1PBR4pm

0 · Reply

Sensore Feb. 10 at 7:06 PM

$EVGN ..

0 · Reply

Trader1141 Feb. 10 at 6:32 PM

$EVGN I think ST should check people’s age before they let them open an account… sheesh 😎

0 · Reply

topstockalerts Feb. 10 at 6:31 PM

Evogene announced an expanded collaboration with Google Cloud to integrate advanced AI agents into its ChemPass AI platform. The partnership will leverage Google Cloud’s Vertex AI to enhance Evogene’s small-molecule discovery and optimization capabilities for pharmaceutical and agricultural applications. This marks the second major milestone in the companies’ relationship, following their initial collaboration announced in October 2024. The integration aims to automate and scale key discovery processes, enabling large-scale parallel molecular exploration while shortening design-build-test-analyze cycles. Evogene expects the upgrades to improve precision, success rates, speed, and cost efficiency across multiple discovery programs. CEO Ofer Haviv said the collaboration represents a shift from AI models to autonomous discovery, adding that parts of Evogene’s innovation tools may eventually be offered globally via the Google Cloud Marketplace. $EVGN

1 · Reply

bloodtrailer Feb. 10 at 6:22 PM

$EVGN are you kidding me????

0 · Reply

suntanner20 Feb. 10 at 3:42 PM

$EVGN is run by a moron. Period end of story. insilico 5b evgn ceo wants to play with pigs on Wall Street.

0 · Reply

Trader1141 Feb. 10 at 2:08 PM

$VELO Will news be good enough to flip it from extremely bearish to bullish? $EVGN $EVMN $ABP

0 · Reply

OpenOutcrier Feb. 10 at 1:52 PM

$EVGN (+6.4% pre) Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™ https://ooc.bz/l/92725

0 · Reply

Trader1141 Feb. 10 at 1:52 PM

$EVGN think about it in the news was true this would’ve exploded

1 · Reply

Mervolo Feb. 10 at 1:45 PM

$LTNC dunno what this is but guess they giving a few thousand shares lolzzzz. Nice surprise though, thanks baphomet ;) $EVGN ready for ROUND TWO but wary of the usually p$D and kinda feelin lazy $BYAH that 30 min lookin hella bullish :d Man, two benni s in and still not tired. Can t even fathom looking at the news so just gonna dance (hopefully ear can take an airpod 🤷‍♀️) and look at those pretty pretty charts :*

0 · Reply

Market Cap	4.40M
Revenue (ttm)	8.51M
Net Income (ttm)	-16.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-193.77%
Debt to Equity Ratio	0.00

Volume	70,900
Avg Vol	523,640
Day's Range	N/A - N/A
Shares Out	5.37M
Stochastic %K	2%
Beta	1.35
Analysts	Strong Buy
Price Target	$2.50